Taro Pharmaceutical Industries Ltd expected to post earnings of 91 cents a share - Earnings Preview

Taro Pharmaceutical Industries

25/01/2022 21:43

* Taro Pharmaceutical Industries Ltd  TARO.N   TARO.K  is
expected
to show a rise in quarterly revenue when it reports  results on
January 27. 
    * The Haifa Israel-based   company is expected to report  a
1.5% increase in revenue to $142.223 million from $140.15
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Taro Pharmaceutical
Industries Ltd is for earnings of 91 cents per share. For the
same quarter last year, the company reported earnings of 86
cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $75​, about 38.6% above​ its
last closing price of $46.06. ​​​

This summary was machine generated January 25 at 21:43 GMT.  All
figures in US dollars  unless otherwise stated